Histopathological section staining
Observe tissue morphology and lesions, including plaque section staining in atherosclerosis research.
Examine tissue pathology with section staining and immunohistochemistry.
Observe tissue morphology and lesions, including plaque section staining in atherosclerosis research.
Immunohistochemistry to examine the distribution of target markers in tissue.
Explore gene expression and protein measures with qPCR, ELISA and WB.
Quantitative PCR analysis to measure target gene expression.
Enzyme-linked immunosorbent analysis to measure target proteins in samples.
Western blot analysis to examine target protein expression.
Explore molecular changes in tissues and cells through transcriptomic data in model research.
Analyze gene expression at single-cell resolution, including hippocampal tissue in Alzheimer’s disease model research.
Sample requirements, assay scope, deliverables and current availability are confirmed for each research project.
测定对象为反转录产物中目标序列的实时扩增量,原始观测为循环阈值(Cq),需经扩增效率校正后转换为可比较的目标量。
Protocols apply a method to a defined measurement, with samples, procedures and quality controls. Available services are linked separately.
Version 3
Quantifies mouse or rat urinary albumin on a 96-well plate with the Albumin Blue 580 dye-binding reagent and fluorescence readout, following the pinned protocol series-dilution, plating, reading and curve-fitting steps.
Version 4
This protocol adopts the FFPE branch of the protocols.io PAS staining protocol for human kidney tissue v3. Paraffin sections are dewaxed in xylene, rehydrated through graded alcohols, oxidized with periodic acid, stained with Schiff reagent, counterstained with hematoxylin, dehydrated, cleared and coverslipped to demonstrate glomerular basement membranes, mesangial matrix and glycoproteins. The record describes the staining procedure, not executed disease-model results.
Version 1
Freshly prepared streptozotocin (7.5 mg/ml in pH 4.5 sodium citrate buffer) injected intraperitoneally at 50 mg/kg for five consecutive days in fasted, isoflurane-anesthetized mice, with hyperglycaemia confirmed at four weeks.
Version 11
This protocol adopts the protocols.io Oral Glucose Tolerance Test in Mouse v1. Mice are fasted for 4–6 hours, weighed, and given oral glucose at 1 g/kg (0.5 g/kg after at least 4 weeks of high-fat diet). Blood glucose is measured before and at 15, 30, 60, 90 and 120 minutes after the load, with tail-vein plasma collected at selected time points for insulin measurement. The record describes the assay procedure, not executed disease-model results.
Version 10
This protocol adopts the protocols.io Oral Glucose Tolerance Test in Mouse v1. Mice are fasted for 4–6 hours, weighed, and given oral glucose at 1 g/kg (0.5 g/kg after at least 4 weeks of high-fat diet). Blood glucose is measured before and at 15, 30, 60, 90 and 120 minutes after the load, with tail-vein plasma collected at selected time points for insulin measurement. The record describes the assay procedure, not executed disease-model results.
Version 7
This protocol adopts the protocols.io Oral Glucose Tolerance Test in Mouse v1. Mice are fasted for 4–6 hours, weighed, and given oral glucose at 1 g/kg (0.5 g/kg after at least 4 weeks of high-fat diet). Blood glucose is measured before and at 15, 30, 60, 90 and 120 minutes after the load, with tail-vein plasma collected at selected time points for insulin measurement. The record describes the assay procedure, not executed disease-model results.
Version 4
Measure rat tail-vein blood glucose using Roche Accutrend Plus test strips and meter.
Version 4
A rat water-maze procedure using an automated Atlantis platform and distal cues, with a new platform location each day. Preserve the separate platform-found and platform-not-found paths, and record escape latency and swim trajectories across the successive trials.
Version 5
This protocol adopts the protocols.io Picrosirius red staining for histology v1. Formalin-fixed paraffin-embedded sections are dewaxed and rehydrated, optionally pre-treated with phosphotungstic acid and counterstained with Weigert haematoxylin, then stained with 0.1% Sirius Red F3BA in saturated picric acid, differentiated with acetic acid, dehydrated, cleared and mounted. Collagen appears red in bright field and birefringent under polarised light. The record describes staining and microscopic observation, not a complete fibrosis area or stage quantification.
Version 7
Hematoxylin and eosin (H&E) staining of fixed, paraffin-embedded tissue sections (4 μm). The workflow covers dewaxing, rehydration, hematoxylin nuclear staining, bluing, eosin counterstaining, dehydration and clearing, and coverslipping, yielding blue-purple nuclei and pink cytoplasm and connective tissue fibers for light-microscopic assessment of cellular and tissue morphology.